Literature DB >> 594386

Synthesis of thromboxane B2 and prostaglandins by bovine gastric mucosal microsomes.

M Ali, J Zamecnik, A L Cerskus, A J Stoessl, W H Barnett, J W McDonald.   

Abstract

Bovine gastric mucosal microsomes synthesize prostaglandins from arachidonic acid but thromboxane B2 is the principal product. Thromboxane B2 synthesis occurs at an appreciable rate from endogenous precursor but more rapidly with added arachidonate. Nonsteroidal antiinflammatory drugs inhibited synthesis of prostaglandins and thromboxanes with the following decreasing order of potency: indomethacin, fenoprofen, acetylsalicylic acid, phenylbutazone, sulfinpyrazone, and acetaminophen.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 594386     DOI: 10.1016/0090-6980(77)90299-4

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  6 in total

Review 1.  Introduction: thromboxane in biological systems and the possible impact of its inhibition.

Authors:  M Verstraete
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

2.  Inhibitors of prostaglandin dehydrogenase (Ph CL 28A and Ph CK 61A) increase output of prostaglandins from rat isolated lung.

Authors:  Y S Bakhle; J J Pankhania
Journal:  Br J Pharmacol       Date:  1987-09       Impact factor: 8.739

3.  Diflunisal protects human gastric mucosa against damage by indomethacin.

Authors:  M M Cohen
Journal:  Dig Dis Sci       Date:  1983-12       Impact factor: 3.199

Review 4.  Sulfinpyrazone: a review of its pharmacological properties and therapeutic use.

Authors:  E H Margulies; A M White; S Sherry
Journal:  Drugs       Date:  1980-09       Impact factor: 9.546

5.  Mechanisms of Forssman-induced bronchospasm and their inhibition.

Authors:  K D Butler; J R Smith
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

6.  Metabolites of arachidonic acid formed by human gastrointestinal tissues and their actions on the muscle layers.

Authors:  A Bennett; C N Hensby; G J Sanger; I F Stamford
Journal:  Br J Pharmacol       Date:  1981-10       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.